01 1Aurisco Pharmaceutical
01 1FLUTICASONE PROPIONATE USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-27
Pay. Date : 2018-05-09
DMF Number : 20212
Submission : 2007-01-17
Status : Active
Type : II
20
Aurisco Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is FLUTICASONE PROPIONATE USP, with a corresponding US DMF Number 20212.
Remarkably, this DMF maintains an Active status since its submission on January 17, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 27, 2018, and payment made on May 09, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
